Zuzana Diamant Selected Research

Rhinosinusitis

12/2023	EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care.
6/2023	Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.
1/2023	Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
12/2020	Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zuzana Diamant Research Topics

Disease

60	Asthma (Bronchial Asthma) 11/2023 - 01/2004
18	Inflammation (Inflammations) 01/2023 - 06/2005
11	Hypersensitivity (Allergy) 12/2023 - 01/2004
7	Allergic Rhinitis 04/2023 - 01/2004
7	COVID-19 01/2022 - 05/2020
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 08/2011
4	Rhinosinusitis 12/2023 - 12/2020
4	Nasal Polyps (Nasal Polyp) 12/2023 - 01/2023
4	Respiratory Hypersensitivity 03/2022 - 03/2007
3	Airway Remodeling 11/2023 - 01/2009
2	Virus Diseases (Viral Diseases) 01/2022 - 12/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2016
2	Drug Hypersensitivity (Drug Allergy) 12/2020 - 12/2019
2	Food Hypersensitivity (Food Allergy) 12/2020 - 12/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2019 - 01/2019
2	Eosinophilia 01/2016 - 10/2012
1	Disease Progression 04/2024
1	Hypertrophy 11/2023
1	Hyperplasia 11/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Airway Obstruction (Choking) 03/2022
1	Dyspnea (Shortness of Breath) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Infections 01/2021
1	Leukemia 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Urticaria (Hives) 12/2020
1	Atopic Dermatitis (Atopic Eczema) 12/2020
1	Anaphylaxis (Anaphylactic Shock) 12/2020
1	Systemic Mastocytosis 08/2020

Drug/Important Bio-Agent (IBA)

17	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2004
15	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2005
13	AllergensIBA 04/2024 - 03/2007
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021 - 10/2012
5	Immunoglobulin E (IgE)IBA 01/2021 - 01/2004
4	Interleukin-13IBA 01/2023 - 01/2016
4	CytokinesIBA 01/2023 - 01/2004
3	mepolizumabIBA 06/2023 - 01/2023
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022 - 06/2005
3	Prostaglandin D2IBA 01/2022 - 12/2014
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	Bronchodilator Agents (Bronchodilators)IBA 04/2021 - 08/2011
3	indacaterolIBA 04/2021 - 04/2020
3	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2021 - 04/2020
3	LeukotrienesIBA 01/2021 - 01/2004
2	Monoclonal AntibodiesIBA 11/2023 - 06/2023
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2022
2	SteroidsIBA 11/2023 - 01/2017
2	dupilumabIBA 01/2023 - 01/2018
2	anti-IgE antibodiesIBA 01/2023 - 12/2019
2	EicosanoidsIBA 01/2022 - 01/2021
2	Acetates (Acetic Acid Esters)FDA Link 04/2021 - 01/2021
2	ProstaglandinsIBA 01/2021 - 01/2019
2	LipidsIBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 10/2020
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2018 - 01/2004
2	PeriostinIBA 01/2018 - 01/2016
2	InterleukinsIBA 01/2018 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 01/2017 - 01/2016
2	Methacholine Chloride (Methacholine)FDA Link 11/2013 - 01/2005
2	Substance PIBA 03/2007 - 01/2005
2	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 03/2007 - 01/2005
2	Neurokinin AIBA 03/2007 - 01/2005
2	TachykininsIBA 03/2007 - 01/2005
1	Irritants (Vesicants)IBA 04/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	benralizumabIBA 01/2023
1	reslizumabIBA 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	FP-025IBA 01/2023
1	tezepelumabIBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2022
1	ProteomeIBA 03/2022
1	AntipyreticsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	EmollientsIBA 01/2022
1	CannabinoidsIBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Muscarinic AntagonistsIBA 04/2021
1	GoldIBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	ThromboxanesIBA 01/2021
1	EnoximoneIBA 01/2021
1	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2021
1	prostaglandin D2 receptorIBA 01/2021
1	LipoxinsIBA 01/2021
1	Matrix Metalloproteinase 12IBA 01/2021

Therapy/Procedure

31	Therapeutics 11/2023 - 01/2004
6	Precision Medicine 01/2021 - 01/2017
4	Immunotherapy 04/2023 - 05/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2013
3	Biological Therapy 12/2019 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 01/2021